Atlas Trials

Serum Level of Calpains Product as a Novel Biomarker of Acute Lung Injury Following Cardiopulmonary Bypass

Clinical trial NCT05610475 · COMPLETED

Trial details

NCT number
NCT05610475
Sponsor
Yangzhou University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Lung Injury, Acute
Start date
2022-02-01
Primary completion
2022-08-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.